Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry

BACKGROUND: Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and bleeding remains significant and affects the choice of clinicians in the treatment of the single patient. Large registries are effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcucci, Rossella, Patti, Giuseppe, Calabrò, Paolo, Gori, Anna Maria, Grossi, Guido, Cirillo, Plinio, Pengo, Vittorio, Gresele, Paolo, Pignatelli, Pasquale, Antonucci, Emilia, di Mario, Carlo, Valente, Serafina, Palareti, Gualtiero
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629086/
https://www.ncbi.nlm.nih.gov/pubmed/31306454
http://dx.doi.org/10.1371/journal.pone.0219676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629086/
https://www.ncbi.nlm.nih.gov/pubmed/31306454
http://dx.doi.org/10.1371/journal.pone.0219676

Ejemplares similares